MRI Phenotyping Method Concordance in Serbian AD Cohort

Clinical Score: 0.850 Price: $0.50 Alzheimer's disease human patients Status: proposed

What This Experiment Tests

Clinical experiment designed to assess clinical efficacy targeting N/A in human patients. Primary outcome: Concordance between different MRI phenotyping methods

Description

This study assessed the concordance between four different MRI phenotyping methods for Alzheimer's disease in a Serbian cohort of 40 subjects. The four MRI phenotyping approaches compared were: scale-based, adjusted scale-based, volume-based, and thickness-based methods. The study aimed to determine how well these different phenotyping approaches agree with each other in identifying the four predominant MRI phenotypes of AD: typical, hippocampal-sparing, limbic-predominant, and minimal-atrophy. The research also examined relationships with demographic variables and clinical dementia rating (CDR) domains to understand clinical heterogeneity among phenotypes. The findings showed that scale-based methods had moderate agreement with adjusted scale-based approaches and high concordance with volumetric methods, while the relationship with thickness-based phenotyping was less clear.

TARGET GENE
N/A
MODEL SYSTEM
human patients
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
N/A
SOURCE
extracted_from_pmid_41943971
PRIMARY OUTCOME
Concordance between different MRI phenotyping methods

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.850 composite

📖 Wiki Pages

MRI Atrophy Patterns in CBS/PSPbiomarkerMRI and Imaging Findings in Corticobasal SyndromediagnosticMRI for Neurodegenerative DiseasestechnologyAlzheimer's DiseasediseaseAlzheimer's DiseasediseaseAlzheimer's Disease Genetic VariantsdiseaseAlzheimer's Disease vs Parkinson's Disease ComparidiseaseAPP Mutations in Alzheimer's DiseasediseaseDLB, Parkinson's Disease, and Alzheimer's Disease:diseaseEarly-Onset Alzheimer's Disease (EOAD)diseaseInvestment Landscape: Alzheimer's DiseasediseasePreclinical Alzheimer's DiseasediseaseProdromal Alzheimer's DiseasediseasePSEN1 Mutations in Alzheimer's DiseasediseasePSEN2 Mutations in Alzheimer's Diseasedisease

Protocol

Four MRI phenotyping approaches were employed (scale-based, adjusted scale-based, volume-based, and thickness-based) to classify AD patients into four phenotypes (typical, hippocampal-sparing, limbic-predominant, and minimal-atrophy). Agreement between methods was assessed along with relationships to demographic variables and clinical dementia rating domains.

Expected Outcomes

The study expected to determine which MRI phenotyping methods show good concordance and could be used interchangeably in clinical settings, particularly identifying practical approaches for resource-limited settings.

Success Criteria

Significant concordance between MRI phenotyping methods, particularly validation of scale-based methods as practical alternatives to more advanced techniques

Related Hypotheses (5)

TREM2-mediated microglial tau clearance enhancement0.618
LRP1-Dependent Tau Uptake Disruption0.600
VCP-Mediated Autophagy Enhancement0.595
Extracellular Vesicle Biogenesis Modulation0.582
HSP90-Tau Disaggregation Complex Enhancement0.575

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.